| abstract |
The present invention is directed to methods and compositions related to electroprocessed drug delivery devices. An electroprocessed drug delivery device of the present invention can, for example, be made to comprise an electrospun scaffold (e.g. , comprising polydioxanone) incorporated with Monocyte Chemotactic Protein- 1 (MCP-I). The electroprocess drug delivery device can be used to influence macrophage infiltration and adherence, and to allow extended chemokine release. |